Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy.

Gambichler T, Stockfleth E, Susok L.

J Immunother Cancer. 2018 Oct 30;6(1):113. doi: 10.1186/s40425-018-0430-y.

2.

Baseline laboratory parameters predicting clinical outcome in melanoma patients treated with ipilimumab: a single-centre analysis.

Gambichler T, Brown V, Steuke AK, Schmitz L, Stockfleth E, Susok L.

J Eur Acad Dermatol Venereol. 2018 Jun;32(6):972-977. doi: 10.1111/jdv.14629. Epub 2017 Nov 22.

PMID:
29024038
3.

T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid.

Gambichler T, Tsitlakidon A, Skrygan M, Höxtermann S, Susok L, Hessam S.

Clin Exp Dermatol. 2017 Aug;42(6):632-637. doi: 10.1111/ced.13135. Epub 2017 Jun 7.

PMID:
28590036
4.

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.

Gambichler T, Strutzmann S, Tannapfel A, Susok L.

BMC Cancer. 2017 May 12;17(1):327. doi: 10.1186/s12885-017-3313-6.

5.

Val/Val glutathione-S-transferase P1 polymorphism predicts nonresponders in psoriasis patients treated with fumaric acid esters.

Gambichler T, Susok L, Zankl J, Skrygan M.

Pharmacogenet Genomics. 2016 May;26(5):248-53. doi: 10.1097/FPC.0000000000000218.

PMID:
26967570
6.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N; German Network for Systemic Scleroderma.

J Rheumatol. 2016 Jan;43(1):66-74. doi: 10.3899/jrheum.150382. Epub 2015 Nov 15.

7.

Interstitial granulomatous dermatitis associated with myelodysplastic syndrome - complete clearance under therapy with 5-azacytidine.

Patsinakidis N, Susok L, Hessam S, Othlinghaus N, Möllenhoff K, Stücker M, Altmeyer P, Kreuter A.

Acta Derm Venereol. 2014 Nov;94(6):725-6. doi: 10.2340/00015555-1827. No abstract available.

8.

Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.

Zhang Y, Dees C, Beyer C, Lin NY, Distler A, Zerr P, Palumbo K, Susok L, Kreuter A, Distler O, Schett G, Distler JH.

Ann Rheum Dis. 2015 May;74(5):936-43. doi: 10.1136/annrheumdis-2013-204256. Epub 2014 Jan 15.

PMID:
24431397
9.

Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis.

Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler JH, Fierlbeck G, Genth E, Guenther C, Hein R, Henes J, Herich L, Herrgott I, Koetter I, Kreuter A, Krieg T, Kuhr K, Lorenz HM, Meier F, Melchers I, Mensing H, Mueller-Ladner U, Pfeiffer C, Riemekasten G, Sárdy M, Schmalzing M, Sunderkoetter C, Susok L, Tarner IH, Vaith P, Worm M, Wozel G, Zeidler G, Hunzelmann N; all participating DNSS centers.

Ann Rheum Dis. 2015 Apr;74(4):730-7. doi: 10.1136/annrheumdis-2013-204487. Epub 2014 Jan 3.

10.

Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters.

Gambichler T, Kreuter A, Susok L, Skrygan M, Rotterdam S, Höxtermann S, Müller M, Tigges C, Altmeyer P, Lahner N.

J Eur Acad Dermatol Venereol. 2014 May;28(5):574-80. doi: 10.1111/jdv.12137. Epub 2013 Mar 12.

PMID:
23489263
11.

Complete clearance of reticular erythematous mucinosis with quinacrine monotherapy.

Susok L, Kreuter A.

Arch Dermatol. 2012 Jun;148(6):768-9. doi: 10.1001/archdermatol.2012.53. No abstract available.

PMID:
22710470

Supplemental Content

Support Center